Healthcare Professionals

There has been much scientific research using CBD, we at Pureis Academy have summarised some of the scientific studies and what was CBD being assessed for. We have presented this data in the below table, please note this is not an exhaustive list. We at Pureis Academy need to point out these are scientific studies and not clinical trials. In order to have a proven therapeutic benefit a medicine license must be issued by a respective medicine authority.

In June 2018, U.S. Food and Drug Administration (FDA) approved the first oral solution drug (Epidiolex®-a purified form of CBD oil) comprised of CBD as an active ingredient derived from marijuana to treat rare, severe forms of epilepsy. Under orphan approval status Epidiolex® was approved in Europe on the 19th of September 2019 for treating two types of epilepsy: LennoxGastaut syndrome and Dravet syndrome. There is no other pure CBD approved as a licensed drug at this time.

Dr Pritchard

Dr Pritchard discusses Healthcare

Stay Connected

Sign Up to Stay Up to Date!

The first CBD food supplement clinically proven to be safe

Sign up to get 10% off your first order!

By clicking SUBMIT you agree to receiving future communications from Pureis. Read our full privacy policy.

newsletter modal